Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Sanofi Provides Fitusiran Trial Updates at ISTH
Sanofi Provides Fitusiran Trial Updates at ISTH
Industry
Prophylactic Therapy for Glanzmann Thrombasthenia Moves Towards Clinical Trials
Prophylactic Therapy for Glanzmann Thrombasthenia Moves Towards…
Industry
Scientist using Microscope in a clinical trial
Sanofi and Sobi® Report Progress with BIVV001 at International Congress
Industry
Ampoule bottle assembly line banner
Bayer Announces Discontinuation of Kogenate® FS
Industry
Blood Cells Image
FDA Grants Breakthrough Status to BIVV001
Industry
DNA Gene Helix
FDA Accepts Priority Review BLA for Hemophilia B Gene Therapy
Industry
First Patient Dosed in Freeline’s Dose-Confirmation Trial for Hemophilia B Gene Therapy
First Patient Dosed in Freeline’s Dose-Confirmation Trial for…
Industry
BioMarin Provides Update Including Next Steps for Investigational Gene Therapy
BioMarin Provides Update Including Next Steps for Investigational Gene…
Industry
Sigilon Announces a Priority Shift in Light of Clinical Trial Setbacks
Sigilon Announces a Priority Shift in Light of Clinical Trial Setbacks
Industry
uniQure and CSL Behring Announce Trial Updates for Hemophilia B Gene…
Industry
Sigilon Reports Trial Updates for Investigational Hemophilia A Therapy
Industry
Spark Announces Multiyear Data Update for Investigational Gene Therapy
Spark Announces Multiyear Data Update for Investigational Gene Therapy
NBDF & Community
Washington D.C. - Capitol Building
NHF Applauds Implementation of the Hemophilia SNF Access Act
Medical
Prophylaxis Indication Restored for BeneFIX®
Industry
Spark Provides Trial Updates for Investigational Gene Therapy SPK-8011
Spark Provides Trial Updates for Investigational Gene Therapy SPK-8011